Showing results (151-160 of 251) with videos related to
Sort By:
Pageof 26
Journal of Cellular Physiology|June 1, 2021
DL-3-n-butylphthalide-induced neuroprotection in rat models of asphyxia-induced cardiac arrest followed by cardiopulmonary resuscitationSong Yang, Changxiao Yu, Zhengfei Yang, et al.Resuscitation|April 14, 2020
In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, ChinaFei Shao, Shuang Xu, Xuedi Ma, et al.Cancer Medicine|March 8, 2024
CD2AP is a potential prognostic biomarker of renal clear cell carcinomaCan Chen, Jia Xu, Jie-Xin Zhang, et al.Nature Cancer|October 21, 2022
Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockadeFei Shao, Yibo Gao, Wei Wang, et al.Frontiers in Immunology|May 31, 2021
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell CarcinomaWei Guo, Fengwei Tan, Qilin Huai, et al.BMC Cancer|July 14, 2023
Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancerWandi Li, Zhaopei Liu, Kaifeng Jin, et al.Journal of Neuro-Oncology|July 29, 2015
Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patientsJian-tong Jiao, Jun Sun, Jian-fen Ma, et al.British Journal of Cancer|August 23, 2022
Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patientsChunnan Liu, Zhaopei Liu, Kaifeng Jin, et al.British Journal of Cancer|April 25, 2025
Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancerMengyao Sun, Yun Gu, Jieti Wang, et al.Lipids|September 10, 2011
Electrospray ionization tandem mass spectrometry of sodiated adducts of cholesteryl estersJohn A Bowden, Fei Shao, Carolyn J Albert, et al.Pageof 26